MedHorizons About us All journals All articles Submit your research Search
MH
MedHorizon in Oncology
Sections Articles Research Topics Editorial board About journal
Submit your research πŸ”

All Articles

Browse the latest research articles across all MedHorizons journals.

Review

Blood–Brain Barrier Penetration of Novel BTK Inhibitors: Implications for CNS Lymphoma Treatment

Chen F, Liu Y, Wang H, et al.
πŸ“„ 89 citations πŸ‘ 12,541 views J. Hematol. Oncol. Neuro-Lymphoma Res. Jul 30, 2025
Case Report

Glofitamab Intrathecal Administration in Richter Transformation With Isolated CNS Relapse

Wang L, Xu Z, Song Y, et al.
πŸ“„ 14 citations πŸ‘ 3,218 views Front. Oncol. Oct 21, 2025
Original Research

Venetoclax, Zanubrutinib, Selinexor, Glofitamab (IV + IT), Intrathecal Cytarabine, Obinutuzumab, and Involved-Field Radiation Therapy in Heavily Pretreated Secondary CNS DLBCL

Wei Jianming, Chen Lihua, Zhou Fang, Xu Mingzhi, Liu Yanhong
πŸ“„ 12 citations πŸ‘ 3,847 views J. Hematol. Oncol. Neuro-Lymphoma Res. Sep 9, 2025
Original Research

Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series

Zhang Y, Li Y, Zhuang Z, et al.
πŸ“„ 66 citations πŸ‘ 9,521 views J. Hematol. Oncol. Neuro-Lymphoma Res. Aug 14, 2025
Systematic Review

Efficacy and Safety of BTK Inhibitors in Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

Liu J, Huang D, Wu F, et al.
πŸ“„ 78 citations πŸ‘ 15,103 views J. Hematol. Oncol. Neuro-Lymphoma Res. Jul 3, 2025
Clinical Trial

Phase II Trial of Pirtobrutinib Plus Venetoclax in Relapsed/Refractory Mantle Cell Lymphoma with CNS Involvement

Morales J, Kim S, Rajput A, et al.
πŸ“„ 31 citations πŸ‘ 7,844 views Front. Oncol. β€” Hematologic Malignancies Jun 18, 2025
Original Research

Selinexor as a CNS-Penetrant Backbone in Combination Salvage Therapy: Updated Multicenter Experience in 42 Patients

Park H, O'Brien C, Tanaka M, et al.
πŸ“„ 47 citations πŸ‘ 6,291 views Blood Cancer Journal May 27, 2025
Review

CAR-T Cell Therapy for Secondary CNS Lymphoma: Challenges, Current Data, and Future Directions

Fischer R, Zhao W, LindstrΓΆm A, et al.
πŸ“„ 54 citations πŸ‘ 11,082 views J. Hematol. Oncol. Neuro-Lymphoma Res. May 12, 2025

Filter by Type

Filter by Date

Popular Keywords

DLBCL CNS lymphoma Venetoclax BTK inhibitors Bispecific antibody CAR-T Selinexor Blood-brain barrier

Journals

J. Hematol. Oncol. Neuro-Lymphoma Res. MedHorizon in Oncology Blood Cancer Journal Frontiers in Immunology

About MedHorizons

Who we are Mission and values History Leadership

Publishing Model

How we publish Open access Peer review Research integrity

For Authors

Why submit? Article types Author guidelines Publishing fees

More from MedHorizons

MedHorizons Forum Press office Career opportunities Contact us
Β© 2025 MedHorizons. Open Access under Creative Commons Attribution 4.0 International License (CC BY 4.0). All rights reserved. | Privacy Policy | Terms and Conditions